
Annual Giving
$6.9M+9% YoY
Grants
47
Median Grant
$24K
Organizations Funded
58
SciRise maps the network of who funds whom to surface your next funders. Enter your nonprofit to check your fit.
LLHF's mission is to advance medical science by supporting basic and clinical research and initiatives related to patient self-care and management, focusing on diabetes mellitus and chronic degenerative diseases associated with aging, particularly brain and vision disorders.
42 awards in 2023, 52 awards in 2022. Start-up grants up to $120,000/year for 3 years. Fellowship grants for post-doctoral training. Network grants for collaborative research. $127,500 in scholarships awarded in 2024.
Must create account on llhf.org. Multiple grant types: Start-up (due Jan 31), Fellowship, Network. PI lab must be affiliated with California institution. Focus areas: diabetes and aging research.
Faculty with >3 years experience excluded from Start-up grants. Focus restricted to California institutions, diabetes and aging research only.
Based on publicly available information from the foundation's 990 filings and website.
$6.9M
Grants
47
Median
$24K
States
2
$6.3M
Grants
42
Median
$40K
States
3
$7.0M
Grants
52
Median
$25K
States
3
$24K
Typical Grant (Median)
$4K
Smallest
$10K
25th Pctile
$73K
75th Pctile
$1.9M
Largest
Excludes grants ≤ $5K. Half fall between $10K and $73K.
$1.9M
2024
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
CA · GENERAL SUPPORT
$1.5M
2024
UNIVERSITY OF CALIFORNIA SAN DIEGO
CA · GENERAL SUPPORT
$600K
2024
SALK INSTITUTE
CA · GENERAL SUPPORT
$545K
2024
BUCK INSTITUTE
CA · GENERAL SUPPORT
$370K
2024
STANFORD UNIVERSITY
CA · GENERAL SUPPORT
Top states by total grant dollars. Based on IRS filing data.
Grants paid shown as percentage of total assets
Data sourced from IRS 990 and 990-PF filings and publicly available foundation websites. Grant data, financial figures, and organizational details reflect historical filings and may not represent current operations or funding priorities. Verify directly with the foundation before applying. See an issue? Let us know.